Key result
Genetic testing diagnoses familial hypercholesterolemia reliably but misses causative mutations in up to ~40% of cases.
Answers are grounded in this paper and cite their sources.
Lipid disorders play a critical role in the intricate development of atherosclerosis and its clinical consequences, such as coronary heart disease and stroke. These disorders are responsible for a significant number of deaths in many adult populations worldwide. Familial hypercholesterolemia (FH) is a genetic disorder that causes extremely high levels of LDL cholesterol. The most common mutations occur in genes responsible for low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), or proprotein convertase subtilisin/kexin type 9 (PCSK9). While genetic testing is a dependable method for diagnosing the disease, it may not detect primary mutations in 20%-40% of FH cases.
No takes yet. Share an insight, caveat, or question.
Rogozik et al. (2023) conducted a review in Familial hypercholesterolemia. Genetic testing was evaluated. Genetic testing is a dependable diagnostic method for familial hypercholesterolemia, but it may fail to detect primary mutations in 20% to 40% of cases.
Synapse has enriched 10 related papers. Consider them for comparative context: